# Healthcare Realty Trust Inc: overview

HR · NYSE · CIK 1360604 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hr.md) · [Financials](/companies/hr/financials.md) · [Filings](/companies/hr/filings.md) · [Insiders](/companies/hr/insiders.md)

Latest reported revenue: [$7.9m](/filings/0001360604-26-000070.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001360604-26-000070).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [5,624 d](/filings/0001360604-26-000018.md) | [6,389](/filings/0001360604-26-000042.md) | [6,983](/filings/0001360604-26-000064.md) | [6,886](/filings/0001360604-26-000070.md) | [7,958 d](/filings/0001360604-26-000018.md) | [7,703](/filings/0001360604-26-000042.md) | [8,033](/filings/0001360604-26-000064.md) | [7,915](/filings/0001360604-26-000070.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [(1899.8%) d](/filings/0001360604-26-000018.md) | [(702.3%)](/filings/0001360604-26-000042.md) | [(2260.5%)](/filings/0001360604-26-000064.md) | [(838.5%)](/filings/0001360604-26-000070.md) | [180.8% d](/filings/0001360604-26-000018.md) | [(0.7%)](/filings/0001360604-26-000042.md) | [(541.7%)](/filings/0001360604-26-000064.md) | [(199.1%)](/filings/0001360604-26-000070.md) |
| Diluted EPS | $ per share | not reported | [(0.13)](/filings/0001360604-26-000042.md) | [(0.45)](/filings/0001360604-26-000064.md) | [(0.17)](/filings/0001360604-26-000070.md) | not reported | [0.00](/filings/0001360604-26-000042.md) | [(0.13)](/filings/0001360604-26-000064.md) | [(0.05)](/filings/0001360604-26-000070.md) |
| Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [10.3](/filings/0001360604-24-000026.md) | [13.7](/filings/0001360604-25-000032.md) | [17.5](/filings/0001360604-26-000018.md) | [19.2](/filings/0001360604-26-000018.md) | [28.2](/filings/0001360604-26-000018.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [647.7%](/filings/0001360604-24-000026.md) | [298.4%](/filings/0001360604-25-000032.md) | [(1594.5%)](/filings/0001360604-26-000018.md) | [(3416.4%)](/filings/0001360604-26-000018.md) | [(872.1%)](/filings/0001360604-26-000018.md) |
| Diluted EPS | $ per share | [0.45](/filings/0001360604-24-000026.md) | [0.15](/filings/0001360604-25-000032.md) | [(0.74)](/filings/0001360604-26-000018.md) | [(1.81)](/filings/0001360604-26-000018.md) | [(0.71)](/filings/0001360604-26-000018.md) |
| Free cash flow | $m | [135](/filings/0001360604-24-000026.md) | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hr/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.15bn | 57,045,264 |  | Added +2,200,701 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $585.9m | 29,049,740 |  | Added +426,341 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $337.7m | 16,743,817 |  | Reduced −326,118 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $314.2m | 15,579,097 |  | Added +7,007 |
| [Resolution Capital Ltd](/funds/1612389.md) | 2026-06-30 | $244.8m | 12,135,370 |  | Reduced −1,898,997 |
| [APG Asset Management US Inc.](/funds/1323255.md) | 2026-06-30 | $207.4m | 10,223,995 |  | Unchanged |
| [Daiwa Securities Group Inc.](/funds/1481045.md) | 2026-06-30 | $163.5m | 8,105,312 |  | Reduced −317,663 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $150.1m | 7,440,510 |  | Added +109,754 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $147.4m | 7,305,359 |  | Added +44,345 |
| [RUSH ISLAND MANAGEMENT, LP](/funds/1736465.md) | 2026-06-30 | $105.2m | 5,213,764 |  | Reduced −2,011,598 |

## Recent filings

[All 1,206 filings](/companies/hr/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:06 ET | [10-Q](/filings/0001360604-26-000070.md) | Quarterly report, period 2026-09-30 | 0001360604-26-000070 |
| 2026-10-29 | 16:05 ET | [8-K](/filings/0001360604-26-000069.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001360604-26-000069 |
| 2026-07-31 | 17:17 ET | [8-K](/filings/0001628280-26-051458.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-051458 |
| 2026-07-30 | 16:07 ET | [10-Q](/filings/0001360604-26-000064.md) | Quarterly report, period 2026-06-30 | 0001360604-26-000064 |
| 2026-07-30 | 16:05 ET | [8-K](/filings/0001360604-26-000063.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001360604-26-000063 |
| 2026-05-20 | 16:08 ET | [8-K](/filings/0001360604-26-000051.md) | 5.07 Shareholder vote results | 0001360604-26-000051 |
| 2026-05-19 | 16:27 ET | [8-K](/filings/0001360604-26-000049.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001360604-26-000049 |
| 2026-05-07 | 16:21 ET | [8-K](/filings/0001360604-26-000047.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001360604-26-000047 |
| 2026-05-05 | 06:55 ET | [8-K](/filings/0001360604-26-000045.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001360604-26-000045 |
| 2026-05-01 | 16:10 ET | [10-Q](/filings/0001360604-26-000042.md) | Quarterly report, period 2026-03-31 | 0001360604-26-000042 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001360604-26-000018.md), filed Feb 13, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/99e4ff0c-48cd-4a69-9662-c93749e140b6)

## About the filer

- CIK: 1360604
- Tickers: HR
- Exchange: NYSE
- SIC code: 6798 Real Estate Investment Trusts
- State of incorporation: not reported
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 17:10 ET. No prices; not investment advice.